1191 related articles for article (PubMed ID: 21819472)
1. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
2. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals.
Shuper PA; Joharchi N; Irving H; Fletcher D; Kovacs C; Loutfy M; Walmsley SL; Wong DK; Rehm J
AIDS Care; 2016 Aug; 28(8):954-62. PubMed ID: 26971360
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.
Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Carrieri P; Neau D; Morlat P; Marchou B; Dabis F; Salmon D;
HIV Med; 2013 Aug; 14(7):430-6. PubMed ID: 23461846
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.
Rey D; Carrieri MP; Spire B; Loubière S; Dellamonica P; Gallais H; Cassuto GP; Gastaut JA; Obadia Y;
J Urban Health; 2004 Mar; 81(1):48-57. PubMed ID: 15047783
[TBL] [Abstract][Full Text] [Related]
5. Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection.
Zhang S; Rust G; Cardarelli K; Felizzola J; Fransua M; Stringer HG
AIDS Care; 2015; 27(7):829-35. PubMed ID: 25814041
[TBL] [Abstract][Full Text] [Related]
6. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
Deming P; McNicholl IR
Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
[TBL] [Abstract][Full Text] [Related]
7. Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects.
Marcellin F; Préau M; Dellamonica P; Ravaux I; Kurkdji P; Protopopescu C; Carrieri MP; Spire B
J Pain Symptom Manage; 2007 Oct; 34(4):413-21. PubMed ID: 17616331
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
[TBL] [Abstract][Full Text] [Related]
9. Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.
Roux P; Lions C; Cohen J; Winnock M; Salmon-Céron D; Bani-Sadr F; Sogni P; Spire B; Dabis F; Carrieri MP;
Antivir Ther; 2014; 19(2):171-8. PubMed ID: 24166726
[TBL] [Abstract][Full Text] [Related]
10. HIV and hepatitis C virus coinfection: bad bedfellows.
Schooley RT
Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
[TBL] [Abstract][Full Text] [Related]
11. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
Eslam M; López-Cortés LF; Romero-Gomez M
Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort.
Loko MA; Bani-Sadr F; Valantin MA; Lascoux-Combe C; Fontaine H; Bonnard P; Gervais A; Bouchaud O; Garipuy D; Quertainmont Y; Vittecoq D; Tehrani MS; Winnock M; Dabis F; Salmon D;
Antivir Ther; 2012; 17(7):1335-43. PubMed ID: 23052829
[TBL] [Abstract][Full Text] [Related]
13. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
Nguyen OK; Dore GJ; Kaldor JM; Hellard ME;
Int J Drug Policy; 2007 Oct; 18(5):447-51. PubMed ID: 17854736
[TBL] [Abstract][Full Text] [Related]
14. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients.
Braun DL; Rauch A; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Metzner KJ; Böni J; Weber R; Fehr J
HIV Med; 2014 Nov; 15(10):625-30. PubMed ID: 24894776
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.
Medrano J; Resino S; Vispo E; Madejón A; Labarga P; Tuma P; Martín-Carbonero L; Barreiro P; Rodriguez-Novoa S; Jiménez-Nacher I; Soriano V
J Viral Hepat; 2011 May; 18(5):325-30. PubMed ID: 20456635
[TBL] [Abstract][Full Text] [Related]
18. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
[TBL] [Abstract][Full Text] [Related]
19. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
20. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia.
Wisaksana R; Indrati AK; Fibriani A; Rogayah E; Sudjana P; Djajakusumah TS; Sumantri R; Alisjahbana B; van der Ven A; van Crevel R
Addiction; 2010 Jun; 105(6):1055-61. PubMed ID: 20331555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
